Generate a tailored SOP for Dr. Martin Kerschensteiner. Improve your application with a focused, well-structured draft.
Martin Kerschensteiner is a full professor and director of the Institute of Clinical Neuroimmunology at the University Hospital Biomedical Center, LMU Munich. His research focuses on immune-mediated damage to the central nervous system, particularly in multiple sclerosis. He seeks to understand how immune cells contribute to nervous system damage and aims to develop strategies for neuroprotection and repair. His work includes the use of genetic and pharmacological techniques to foster tissue protection and repair in neuroinflammatory conditions. Kerschensteiner's academic path includes his establishment as a group leader and associate professor at the same institute, as well as valuable postdoctoral experiences in renowned labs at Harvard University and ETH Zurich. He earned his medical degree from LMU Munich in 2000.
Institute of Clinical Neuroimmunology, University Hospital, Biomedical Center, LMU Munich • Munich, Germany
Director of the Institute of Clinical Neuroimmunology.
Institute of Clinical Neuroimmunology, University Hospital, Biomedical Center, LMU Munich • Munich, Germany
Led a research group focusing on neuroimmunology.
Lichtman Lab, Department of Molecular and Cellular Biology, Harvard University • Cambridge, MA, USA
Engaged in research on molecular biology techniques.
Schwab Lab, Brain Research Institute, ETH Zurich • Zurich, Switzerland
Contributed to research in brain injury and repair mechanisms.
Administered by the Faculty of Economics. GRE is NOT required for the standard M.Sc. Economics.